Ocuphire Pharma Probability of Future Stock Price Finishing Over 1.33
| OCUPDelisted Stock | USD 1.13 0.06 5.04% |
Ocuphire |
Ocuphire Pharma Target Price Odds to finish over 1.33
The tendency of Ocuphire Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 1.33 or more in 90 days |
| 1.13 | 90 days | 1.33 | about 61.03 |
Based on a normal probability distribution, the odds of Ocuphire Pharma to move over $ 1.33 or more in 90 days from now is about 61.03 (This Ocuphire Pharma probability density function shows the probability of Ocuphire Stock to fall within a particular range of prices over 90 days) . Probability of Ocuphire Pharma price to stay between its current price of $ 1.13 and $ 1.33 at the end of the 90-day period is about 24.96 .
Given the investment horizon of 90 days Ocuphire Pharma has a beta of -0.13. This indicates as returns on the benchmark increase, returns on holding Ocuphire Pharma are expected to decrease at a much lower rate. During a bear market, however, Ocuphire Pharma is likely to outperform the market. Additionally Ocuphire Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Ocuphire Pharma Price Density |
| Price |
Predictive Modules for Ocuphire Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocuphire Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocuphire Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocuphire Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ocuphire Pharma is not an exception. The market had few large corrections towards the Ocuphire Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ocuphire Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ocuphire Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.74 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 0.25 | |
Ir | Information ratio | -0.2 |
Ocuphire Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ocuphire Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ocuphire Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ocuphire Pharma is now traded under the symbol IRD. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Ocuphire Pharma is not yet fully synchronised with the market data | |
| Ocuphire Pharma generated a negative expected return over the last 90 days | |
| Ocuphire Pharma may become a speculative penny stock | |
| Ocuphire Pharma has high historical volatility and very poor performance | |
| Ocuphire Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.05 M. Net Loss for the year was (9.99 M) with loss before overhead, payroll, taxes, and interest of (14.58 M). | |
| Ocuphire Pharma currently holds about 17.15 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83. |
Ocuphire Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ocuphire Stock often depends not only on the future outlook of the current and potential Ocuphire Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ocuphire Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 50.5 M |
Ocuphire Pharma Technical Analysis
Ocuphire Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ocuphire Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ocuphire Pharma. In general, you should focus on analyzing Ocuphire Stock price patterns and their correlations with different microeconomic environments and drivers.
Ocuphire Pharma Predictive Forecast Models
Ocuphire Pharma's time-series forecasting models is one of many Ocuphire Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ocuphire Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ocuphire Pharma
Checking the ongoing alerts about Ocuphire Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ocuphire Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ocuphire Pharma is now traded under the symbol IRD. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Ocuphire Pharma is not yet fully synchronised with the market data | |
| Ocuphire Pharma generated a negative expected return over the last 90 days | |
| Ocuphire Pharma may become a speculative penny stock | |
| Ocuphire Pharma has high historical volatility and very poor performance | |
| Ocuphire Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 19.05 M. Net Loss for the year was (9.99 M) with loss before overhead, payroll, taxes, and interest of (14.58 M). | |
| Ocuphire Pharma currently holds about 17.15 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83. |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |